9751060 |
IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. |
9891086 |
IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. |
9927690 |
Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. |
10087442 |
Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28. |
10364167 |
Role of adapter function in oncoprotein-mediated activation of NF-kappaB: human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. |
10839543 |
Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. |
10944468 |
cDNA cloning by amplification of circularized first strand cDNAs reveals non-IRE-regulated iron-responsive mRNAs. |
11047757 |
A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). |
11064457 |
Activation of IKKalpha and IKKbeta through their fusion with HTLV-I tax protein. |
11080499 |
Role of ikkgamma/nemo in assembly of the IkappaB kinase complex. |
11224521 |
Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. |
11242109 |
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappa B signaling. |
11389905 |
Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions. |
11418127 |
CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activation. |
11590134 |
A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. |
11971985 |
Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase. |
12045264 |
Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. |
12133833 |
Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. |
12612076 |
Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation. |
12657630 |
In vivo identification of inducible phosphoacceptors in the IKKgamma/NEMO subunit of human IkappaB kinase. |
12917691 |
The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. |
14651848 |
Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. |
14695475 |
Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. |
14702039 |
Complete sequencing and characterization of 21,243 full-length human cDNAs. |
14754897 |
ZNF216 is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation. |
15100680 |
The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. |
15125833 |
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. |
15229184 |
Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation. |
15356572 |
Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. |
15456791 |
PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages. |
15489334 |
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |
15620648 |
The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. |
15772651 |
The DNA sequence of the human X chromosome. |
16360037 |
PIDD mediates NF-kappaB activation in response to DNA damage. |
16497931 |
Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. |
16547522 |
Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation. |
16818673 |
X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. |
16950813 |
IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. |
17135271 |
Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. |
17728323 |
Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. |
17977820 |
Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity. |
18079694 |
A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. |
18164680 |
Intermolecular disulfide bond formation in the NEMO dimer requires Cys54 and Cys347. |
18313693 |
Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation. |
18462684 |
Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. |
18669648 |
A quantitative atlas of mitotic phosphorylation. |
18691976 |
Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. |
19033441 |
The zinc finger of NEMO is a functional ubiquitin-binding domain. |
19136968 |
Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. |
19185524 |
Structural basis for recognition of diubiquitins by NEMO. |
19854139 |
Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. |
19854204 |
DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding. |
20010814 |
A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. |
20068231 |
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. |
20434027 |
NEMO gene mutations in Chinese patients with incontinentia pigmenti. |
20724660 |
Polyubiquitin conjugation to NEMO by tripartite motif protein 23 (TRIM23) is critical in antiviral defense. |
21269460 |
Initial characterization of the human central proteome. |
21455173 |
Linear ubiquitination prevents inflammation and regulates immune signalling. |
21455180 |
SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. |
21455181 |
SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. |
21474709 |
TRIM40 promotes neddylation of IKKgamma and is downregulated in gastrointestinal cancers. |
21606507 |
Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. |
22099304 |
Direct, noncatalytic mechanism of IKK inhibition by A20. |
22672233 |
NLRP10 enhances Shigella-induced pro-inflammatory responses. |
23453969 |
IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex. |
24012789 |
Identifying post-translational modifications of NEMO by tandem mass spectrometry after high affinity purification. |
24275569 |
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. |
24339369 |
Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease. |
25861989 |
TRAF family member-associated NF-kappaB activator (TANK) inhibits genotoxic nuclear factor kappaB activation by facilitating deubiquitinase USP10-dependent deubiquitination of TRAF6 ligase. |
26334375 |
IFIT5 positively regulates NF-kappaB signaling through synergizing the recruitment of IkappaB kinase (IKK) to TGF-beta-activated kinase 1 (TAK1). |
28490597 |
Molluscum contagiosum virus protein MC005 inhibits NF-kappaB activation by targeting NEMO-regulated IkappaB kinase activation. |